| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 04/09/2009 | WO2008122667A3 Ureylene derivatives |
| 04/09/2009 | WO2008050168A8 New sulfonamide derivatives as bradykinin antagonists |
| 04/09/2009 | WO2005033282A3 Polyamide compositions and therapeutic methods for treatment of human papilloma virus |
| 04/09/2009 | US20090093643 Process for Production of Benzyloxypyrrolidine Derivative, and Process for Production of Hydrochloride Salt Powder of Optically Active Benzyloxypyrrolidine Derivative |
| 04/09/2009 | US20090093541 Melanin eliminator preparation |
| 04/09/2009 | US20090093534 Mu opioid receptor ligands: methods of use and synthesis |
| 04/09/2009 | US20090093526 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 04/09/2009 | CA2701579A1 Novel aryl potassium channel blockers and uses thereof |
| 04/09/2009 | CA2701115A1 N-hydroxy-naphthalene dicarboxamide and n-hydroxy-biphenyl-dicarboxamide compounds as histone deacetylase inhibitors |
| 04/09/2009 | CA2694843A1 Three-functional pseudo-peptidic reagent, and uses and applications thereof |
| 04/09/2009 | CA2694288A1 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamide and 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazepine-7-carboxamide derivatives, preparation and therapeutic use thereof |
| 04/08/2009 | EP2045237A1 Pyrrole compounds as inhibitors of mycrobacteria, synthesis thereof and intermediates thereto |
| 04/08/2009 | EP2044076A1 Process for the preparation of asenapine and intermediate products used in said process. |
| 04/08/2009 | EP2044073A1 11beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 04/08/2009 | EP2044015A1 New nitrones bearing a positive charge and suitable for use for the trapping of free radicals, and more particularly the peroxide radical |
| 04/08/2009 | EP1833782B1 Cycloalkylamine derivatives |
| 04/08/2009 | EP1606251B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 04/08/2009 | CN101405259A Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 04/08/2009 | CN101404998A Oral agent for promoting synthesis of tissue collagen |
| 04/08/2009 | CN101402554A 2- and 2,5-substituted phenylketo-enols |
| 04/08/2009 | CN100475818C Indolinospiropyran compounds and methods for manufacture |
| 04/08/2009 | CN100475799C Merocyanine derivatives for cosmetic use |
| 04/08/2009 | CN100475778C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient |
| 04/07/2009 | US7514571 Bicyclo derivative |
| 04/07/2009 | US7514563 Process for producing cyano substituted arene boranes and compounds |
| 04/07/2009 | US7514453 Method for enhancing mutant protein activity |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/07/2009 | CA2361998C Aromatic heterocyclic compounds as anti-inflammatory agents |
| 04/07/2009 | CA2341968C Pyrrolobenzodiazepine compounds |
| 04/07/2009 | CA2217737C Thf-containing sulfonamide inhibitors of aspartyl protease |
| 04/02/2009 | WO2009040755A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto |
| 04/02/2009 | WO2009002203A8 Polyfunctional fullerene c60 aminoacid derivatives |
| 04/02/2009 | WO2008157537A3 Compositions and methods of use for treating or preventing lipid related disorders |
| 04/02/2009 | US20090088579 Production Method of N-Vinyl-2-Pyrrolidone |
| 04/02/2009 | US20090088464 Merged ion channel modulating compounds and Uses Thereof |
| 04/02/2009 | US20090088406 N,n-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors |
| 04/01/2009 | EP2041121A1 An enantioselective synthesis of pyrrolidine-substituted flavones |
| 04/01/2009 | EP2041085A1 Pyrrole derivatives and their methods of use |
| 04/01/2009 | EP2041084A1 Co-crystals of pyrrolidinones |
| 04/01/2009 | EP2041083A1 Zofenopril calcium |
| 04/01/2009 | EP2041082A1 Pyrrolidine derivatives having activity at the glyt1 transporter |
| 04/01/2009 | EP2041077A2 Selective androgen receptor modulators, analogs and derivatives thereof and uses thereof |
| 04/01/2009 | EP2040698A2 Oxime compounds and the use thereof |
| 04/01/2009 | EP1646661B1 Living radical polymerization initiator comprising a functional group capable of reacting with polypeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drung obtained therefrom |
| 03/31/2009 | US7511158 Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof |
| 03/31/2009 | US7511157 Hepatitis C inhibitor dipeptide analogs |
| 03/31/2009 | US7511154 For producing (1'benzyl-2-oxo-[1,3']-(R)-bipyrrolidinyl-3-(R,S)-yl)-triphenyl-phosphonium bromide which is an intermediate for antibacterial vinylpyrrolidinone-cephalosporin derivatives, starting with N-benzyl-3-pyrrolidinamine |
| 03/31/2009 | US7511144 Reverse hydroxamic acid derivatives |
| 03/31/2009 | US7511034 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 03/26/2009 | WO2009037642A1 Heterocyclic scaffolds useful for preparation of combinatorial libraries, libraries and methods of preparation thereof |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | WO2009036996A2 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | US20090082576 Synthetic route to abcd-porphyrins |
| 03/26/2009 | US20090082568 Accelerated reduction of organic substances with boranes |
| 03/26/2009 | US20090082422 Deuterium-enriched levetiracetam |
| 03/26/2009 | US20090082421 Crystalline Form B4 of Atorvastatin Magnesium and a Process Thereof |
| 03/26/2009 | US20090082420 Deuterium-enriched vildagliptin |
| 03/26/2009 | US20090082399 Carbamate derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 03/26/2009 | US20090082393 New addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 03/26/2009 | US20090081801 Process for synthesis of pyrrole derivative, an intermediate for atorvastatin |
| 03/26/2009 | US20090080074 Polymer film, polarizing plate protective film, polarizing plate and liquid crystal display device |
| 03/26/2009 | CA2700051A1 Small molecule bradykinin b1 receptor antagonists |
| 03/26/2009 | CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/25/2009 | EP2039682A1 Salts for adding angiotensin conversion enzyme inhibitors to NO-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | EP2039681A1 Cycloalkene derivatives, process for production of the derivatives, and use of the same |
| 03/25/2009 | EP2039680A1 Process for producing ester or alcohol |
| 03/25/2009 | EP1784389A4 Process for atorvastatin calcium amorphous |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1296935B1 Process for the preparation of substituted octanoyl amides |
| 03/25/2009 | CN101395132A Process for preparing a crystalline form of atorvastatin hemi-calcium |
| 03/25/2009 | CN101395131A Method for producing aminoacetylpyrrolidinecarbonitrile derivative and production intermediate thereof |
| 03/25/2009 | CN101392227A Bacillus prodigiosus and prodigiosin producted thereby |
| 03/25/2009 | CN101391975A Process for separation and purification of N-vinyl pyrrolidone |
| 03/25/2009 | CN101391974A Process for production of N-vinyl pyrrolidone |
| 03/25/2009 | CN101391973A Salts for adding angiotensin conversion enzyme inhibitors to no-donor acids, method of preparing same and pharmaceutical compositions containing them |
| 03/25/2009 | CN100471843C Superhigh purity ionic liquid |
| 03/25/2009 | CN100471836C Crystalline forms VI and VII of atorvastatin calcium |
| 03/24/2009 | US7507854 Impurity reduction in Olefin metathesis reactions |
| 03/24/2009 | US7507767 Sulfonamide-containing benzene derivatives which exhibit anti-inflammatory and immunodulatory activity |
| 03/24/2009 | US7507760 Strokes, hypotensive agents, antidepressants,central nervous system disorders, psychological disorders, schizophrenia, alcoholism, drug abuse |
| 03/24/2009 | US7507546 Using intestinal peptide transporter (PEPT1) and/or kidney peptide transporter (PEPT2) to identify modulators which prevent transfer of sarcosine-glycine dipeptide across cells; drug delivery |
| 03/24/2009 | US7507545 Ion channel modulating activity method |
| 03/19/2009 | WO2009035553A2 Analogs of tetramic acid |
| 03/19/2009 | WO2009035543A1 Dual-acting antihypertensive agents |
| 03/19/2009 | WO2009008913A3 P1-nonepimerizable ketoamide inhibitors of hcv ns3 protease |
| 03/19/2009 | WO2008131946A3 Substituted amide derivatives |
| 03/19/2009 | US20090076286 Process for operating a continuous removal of a target product x in the form of fine crystals |
| 03/19/2009 | US20090076285 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound |
| 03/19/2009 | US20090076284 Process for continuously removing a target product x in the form of fine crystals |
| 03/19/2009 | US20090076276 such as (R)-3-(3-hydroxypyrrolidin-1-yl)-N-methyl-N-methoxypropanamide; poly(ADP-ribose)polymerase inhibitors |
| 03/19/2009 | US20090076232 Process for operating a continuous removal of a target product x in the form of fine crystals of the target product x |
| 03/19/2009 | US20090076126 Deuterium-enriched enalapril |
| 03/19/2009 | US20090076125 Deuterium-enriched glimepiride |
| 03/19/2009 | US20090076062 Organic Compounds |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090075954 Soft anticholinergic esters |
| 03/19/2009 | US20090075253 Bioreactive agents |
| 03/18/2009 | EP2035465A2 Method for deprotecting aryl or alkyl sulfonamides of primary or secondary amines |
| 03/18/2009 | EP2035401A2 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics |
| 03/18/2009 | EP2035395A2 Novel processes for the preparation of dpp iv inhibitors |